PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Plasma p-tau217 Discriminates Early-Onset Alzheimer's in Real-World Clinic

plasma p-tau217ALZpathSimoablood biomarkersearly-onset Alzheimer's diseaseEOADneurodegenerative diseasediagnostic accuracyrenal impairmentamyloidtaudementia Neurology / Neuropharmacology
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Chatterjee P, Ivanic S, Southon A, McCarthy C, Patel SK, Christensen M, Darby D, Bush AI, Ayton S, Werden E, Brodtmann A

Citation: Chatterjee P, Ivanic S, Southon A, et al. Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting. Journal of Alzheimer's disease : JAD. 2025;108(1):387-396. doi:10.1177/13872877251376694

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.